Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Dong E E Jiaoco Ltd A (000423 CH)
Watchlist
36
Analysis
Health Care
•
China
Dong-E-E-Jiao Co., Ltd. primarily manufactures and sells traditional Chinese medicine, health care products, health foods, and bio-medicine. The company also engages in gelatin products manufacturing.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Xiamen Yan Palace Bioengineering
•
27 Nov 2023 08:55
Pre-IPO Xiamen Yan Palace Bioengineering (PHIP Updates) - Some Points Worth the Attention
As Yan palace's revenue growth further declines, effectiveness of marketing activities has already decrease. Huge selling expenses erode profit...
Xinyao (Criss) Wang
Follow
345 Views
Share
bearish
•
Xiamen Yan Palace Bioengineering
•
07 Sep 2023 08:55
Pre-IPO Xiamen Yan Palace Bioengineering - Concerns About Profitability and Growth Sustainability
Since the efficacy/actual value of EBN is questionable, marketing/promotion alone cannot drive future performance growth.Yan Palace's profit model...
Xinyao (Criss) Wang
Follow
486 Views
Share
bullish
•
Thematic (Sector/Industry)
•
16 Jul 2023 09:59
China Healthcare Weekly (Jul.14)-TCM Demand Switch, 8% Benchmark Growth Rate, GLP-1 Change Game Rule
8% could be a benchmark growth rate for future healthcare industry. People's TCM demand switch will lead to changes in TCM company's performance....
Xinyao (Criss) Wang
Follow
318 Views
Share
bullish
•
Eoptolink Technology
•
04 Jul 2023 05:40
CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes
We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...
Brian Freitas
Follow
504 Views
Share
bullish
•
China Resources Pharmaceutical
•
12 Jun 2023 08:55
China Resources Pharmaceutical (3320.HK) - Growth Recovery and SOE Advantages Improve the Outlook
China Resources Pharmaceutical is expected to achieve double-digit growth in 2023. Its SOE resource advantage/background are in line with China's...
Xinyao (Criss) Wang
Follow
325 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x